Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study
- PMID: 28572079
- PMCID: PMC5472843
- DOI: 10.2196/jmir.6631
Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study
Abstract
Background: Combination antiretroviral therapy (cART) as treatment for human immunodeficiency virus (HIV) infection is effective and available, but poor medication adherence limits benefits, particularly in vulnerable populations. In a Kenyan randomized controlled trial, a weekly text-messaging intervention (WelTel) improved cART adherence and HIV viral load (VL). Despite growing evidence for short message service (SMS) text-message interventions in HIV care, there is a paucity of data utilizing these interventions in marginalized or female cohorts.
Objective: This study was undertaken to assess whether the standardized WelTel SMS text-message intervention applied to a vulnerable, predominantly female, population improved cART adherence and VL.
Methods: We conducted a repeated measures study of the WelTel intervention in high-risk HIV-positive persons by measuring change in VL, CD4 count, and self-reported adherence 12 months before and 12 months after the WelTel intervention was introduced. Inclusion criteria included VL ≥200 copies/mL, indication for treatment, and meeting vulnerability criteria. Participants were given a mobile phone with unlimited texting (where required), and weekly check-in text messages were sent for one year from the WelTel computer platform. Clinical data were collected for control and intervention years. Participants were followed by a multidisciplinary team in a clinical setting. Outcomes were assessed using Wilcoxon signed ranks tests for change in CD4 and VL from control year to study end and mixed-effects logistic regressions for change in cART adherence and appointment attendance. A secondary analysis was conducted to assess the effect of response rate on the outcome by modeling final log10 VL by number of responses while controlling for mean log10 VL in the control year.
Results: Eighty-five participants enrolled in the study, but 5 withdrew (final N=80). Participants were predominantly female (90%, 72/80) with a variety of vulnerabilities. Mean VL decreased from 1098 copies/mL in the control year to 439 copies/mL at study end (P=.004). Adherence to cART significantly improved (OR 1.14, IQR 1.10-1.18; P<.001), whereas appointment attendance decreased slightly with the intervention (OR 0.81, IQR 0.67-0.99; P=.03). A response was received for 46.57% (1753/3764) of messages sent and 9.62% (362/3764) of text messages sent were replied to with a problem. An outcome analysis examining relationship between reply rate and VL did not meet statistical significance (P=.07), but may be worthy of investigating further in a larger study.
Conclusions: WelTel may be an effective tool for improving cART adherence and reducing VLs among high-risk, vulnerable HIV-positive persons.
Trial registration: Clinicaltrials.gov NCT02603536; https://clinicaltrials.gov/ct2/show/NCT02603536 (Archived by WebCite at http://www.webcitation.org/6qK57zCwv).
Keywords: HIV; engagement; female; mHealth; medication adherence; mobile phone; viral load; vulnerable.
©Elizabeth King, Karen Kinvig, Jonathan Steif, Annie Q Qiu, Evelyn J Maan, Arianne YK Albert, Neora Pick, Ariane Alimenti, Mary H Kestler, Deborah M Money, Richard T Lester, Melanie Caroline Margaret Murray. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 01.06.2017.
Conflict of interest statement
Conflicts of Interest: Dr Richard Lester is the founder of WelTel, the text-messaging platform used in this study. The technology platform was developed by a nonprofit organization, WelTel mHealth Society, and a private company, WelTel Incorporated. Dr Richard Lester has financial as well as professional interests in both organizations. All other authors declare no conflict of interest.
Figures






Similar articles
-
Health Care Provider Utilization and Cost of an mHealth Intervention in Vulnerable People Living With HIV in Vancouver, Canada: Prospective Study.JMIR Mhealth Uhealth. 2018 Jul 9;6(7):e152. doi: 10.2196/mhealth.9493. JMIR Mhealth Uhealth. 2018. PMID: 29986845 Free PMC article.
-
The effect of an interactive weekly mobile phone messaging on retention in prevention of mother to child transmission (PMTCT) of HIV program: study protocol for a randomized controlled trial (WELTEL PMTCT).BMC Med Inform Decis Mak. 2016 Jul 11;16:86. doi: 10.1186/s12911-016-0321-4. BMC Med Inform Decis Mak. 2016. PMID: 27401475 Free PMC article. Clinical Trial.
-
The Implementation of a Text Messaging Intervention to Improve HIV Continuum of Care Outcomes Among Persons Recently Released From Correctional Facilities: Randomized Controlled Trial.JMIR Mhealth Uhealth. 2020 Feb 13;8(2):e16220. doi: 10.2196/16220. JMIR Mhealth Uhealth. 2020. PMID: 32053119 Free PMC article. Clinical Trial.
-
A systematic review and meta-analysis in the effectiveness of mobile phone interventions used to improve adherence to antiretroviral therapy in HIV infection.BMC Public Health. 2019 Jul 9;19(1):915. doi: 10.1186/s12889-019-6899-6. BMC Public Health. 2019. PMID: 31288772 Free PMC article.
-
Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis.JAMA Intern Med. 2016 Mar;176(3):340-9. doi: 10.1001/jamainternmed.2015.7667. JAMA Intern Med. 2016. PMID: 26831740 Review.
Cited by
-
Mobile phone short message service for adherence support and care of patients with tuberculosis infection: Evidence and opportunity.J Clin Tuberc Other Mycobact Dis. 2019 Jun 6;16:100108. doi: 10.1016/j.jctube.2019.100108. eCollection 2019 Aug. J Clin Tuberc Other Mycobact Dis. 2019. PMID: 31720432 Free PMC article. Review.
-
Improving postpartum retention in care for women living with HIV in the United States.AIDS. 2018 Jan 14;32(2):133-142. doi: 10.1097/QAD.0000000000001707. AIDS. 2018. PMID: 29194122 Free PMC article. Review.
-
A Systematic Review on Promoting Adherence to Antiretroviral Therapy in HIV-infected Patients Using Mobile Phone Technology.Appl Clin Inform. 2018 Apr;9(2):450-466. doi: 10.1055/s-0038-1660516. Epub 2018 Jun 20. Appl Clin Inform. 2018. PMID: 29925099 Free PMC article.
-
The first AI-based Chatbot to promote HIV self-management: A mixed methods usability study.HIV Med. 2025 Feb;26(2):184-206. doi: 10.1111/hiv.13720. Epub 2024 Oct 10. HIV Med. 2025. PMID: 39390632 Free PMC article.
-
Enhancing HIV Cognitive Abilities and Self-Management Through Information Technology-Assisted Interventions: Scoping Review.J Med Internet Res. 2025 Jan 13;27:e57363. doi: 10.2196/57363. J Med Internet Res. 2025. PMID: 39805101 Free PMC article.
References
-
- Public Health Agency of Canada . Summary: Estimates of HIV Incidence, Prevalence and Prorportion Undiagnosed in Canada, 2014. Ottawa, ON: Public Health Agency of Canada; 2015. Nov, [2017-02-26]. http://www.catie.ca/sites/default/files/2014-HIV-Estimates-in-Canada-EN.pdf 6oYWkC4PM.
-
- Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493–505. doi: 10.1056/NEJMoa1105243. http://europepmc.org/abstract/MED/21767103 - DOI - PMC - PubMed
-
- Dube S, Boily M, Mugurungi O, Mahomva A, Chikhata F, Gregson S. Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models. J Acquir Immune Defic Syndr. 2008 May 1;48(1):72–81. doi: 10.1097/QAI.0b013e31816bcdbb. - DOI - PubMed
-
- Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001 Jun 15;15(9):1181–1183. - PubMed
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials